Skip to content
OpenCapital
Get started

Viking Therapeutics VKTX Q2 2026 earnings

Reported July 29, 2026 · Before market open

EPS-$1.10Beat by $0.11
EPS estimate-$1.21

Next report

Oct 28, 2026 (in 3 months)
EPS estimate-$1.11

Versus estimates

Diluted EPS

Q2 2026-$1.10Beat by $0.11
Q1 2026-$1.37Miss by $0.36Q4 2025-$1.38Miss by $0.49Q3 2025-$0.81Miss by $0.11Q2 2025-$0.58Miss by $0.14Q1 2025-$0.41Miss by $0.07

Ask the moment Viking Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Viking Therapeutics report Q2 2026 earnings?
Viking Therapeutics (VKTX) reported Q2 2026 earnings on July 29, 2026 before market open.
What were Viking Therapeutics's Q2 2026 revenue and EPS?
Viking Therapeutics reported eps of $-1.10 for Q2 2026.
Did Viking Therapeutics beat estimates in Q2 2026?
EPS beat the consensus estimate of $-1.21 by $0.11.
How did Viking Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 89.7% from $-0.58.
Where can I find Viking Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-323652) and the 10-Q periodic report (0001193125-26-324219) directly on SEC EDGAR. The filing index links above go to sec.gov.